Biological Relevance of RGD‐Integrin Subtype‐Specific Ligands in Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biological Relevance of RGD‐Integrin Subtype‐Specific Ligands in Cancer
Authors
Keywords
-
Journal
CHEMBIOCHEM
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-11-03
DOI
10.1002/cbic.202000626
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Conformationally active integrin endocytosis and traffic: why, where, when and how?
- (2020) Giulia Mana et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Integrin Signaling in Glioma Pathogenesis: From Biology to Therapy
- (2020) Aleksandra Ellert-Miklaszewska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cell adhesion in cancer: Beyond the migration of single cells
- (2020) Michalina Janiszewska et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Transcriptome analyses reveal molecular mechanisms underlying phenotypic differences among transcriptional subtypes of glioblastoma
- (2020) Yuan‐Bo Pan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis
- (2020) Brian D. Adair et al. Nature Communications
- Chapter 22: Structural and signaling functions of integrins
- (2020) Yasmin A. Kadry et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Structure–Activity Relationship of RGD-Containing Cyclic Octapeptide and αvβ3 Integrin Allows for Rapid Identification of a New Peptide Antagonist
- (2020) Aaron Silva et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Shaping Up the Tumor Microenvironment With Cellular Fibronectin
- (2020) Georgios Efthymiou et al. Frontiers in Oncology
- Integrin Crosstalk Contributes to the Complexity of Signalling and Unpredictable Cancer Cell Fates
- (2020) Ivana Samaržija et al. Cancers
- Identification, Characterization, and Optimization of Integrin αvβ6-Targeting Peptides from a One-Bead One-Compound (OBOC) Library: Towards the Development of Positron Emission Tomography (PET) Imaging Agents
- (2019) Yng Tang et al. MOLECULES
- Clinicopathological and prognostic values of fibronectin and integrin αvβ3 expression in primary osteosarcoma
- (2019) Kai Shi et al. World Journal of Surgical Oncology
- Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance
- (2019) Jonathan Cooper et al. CANCER CELL
- Theranostic iRGD peptide containing cisplatin prodrug: Dual-cargo tumor penetration for improved imaging and therapy
- (2019) Hong-Jun Cho et al. JOURNAL OF CONTROLLED RELEASE
- RNA aptamers targeting integrin α5β1 as probes for cyto- and histo-fluorescence in glioblastoma
- (2019) P. Fechter et al. Molecular Therapy-Nucleic Acids
- Role of Integrins in Resistance to Therapies Targeting Growth Factor Receptors in Cancer
- (2019) Elisabete Cruz da Silva et al. Cancers
- Chiral β-lactam-based integrin ligands through Lipase-catalysed kinetic resolution and their enantioselective receptor response
- (2019) Giulia Martelli et al. BIOORGANIC CHEMISTRY
- Novel Integrin αvβ3-Specific Ligand for the Sensitive Diagnosis of Glioblastoma
- (2019) Lei Zhang et al. MOLECULAR PHARMACEUTICS
- Overexpression of PODXL/ITGB1 and BCL7B/ITGB1 accurately predicts unfavorable prognosis compared to the TNM staging system in postoperative pancreatic cancer patients
- (2019) Keisuke Taniuchi et al. PLoS One
- Are Integrins Still Practicable Targets for Anti-Cancer Therapy?
- (2019) Alday-Parejo et al. Cancers
- Arming Tumor-Associated Macrophages to Reverse Epithelial Cancer Progression
- (2019) Hiromi I. Wettersten et al. CANCER RESEARCH
- Innovative Linker Strategies for Tumor‐Targeted Drug Conjugates
- (2019) Alberto Dal Corso et al. CHEMISTRY-A EUROPEAN JOURNAL
- Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins
- (2019) Cédric Zeltz et al. SEMINARS IN CANCER BIOLOGY
- ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer
- (2019) Praneeth R. Kuninty et al. Science Advances
- What Is the Fuss about Integrins and the Tumor Microenvironment?
- (2019) Johannes A. Eble et al. Cancers
- Recruitment of integrin ανβ3 to integrin α5β1-induced clusters enables focal adhesion maturation and cell spreading
- (2019) Carolina Diaz et al. JOURNAL OF CELL SCIENCE
- Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma
- (2019) Fengkai Sun et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Could Dissecting the Molecular Framework of β-Lactam Integrin Ligands Enhance Selectivity?
- (2019) Giulia Martelli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Integrin α5 subunit is required for the tumor supportive role of fibroblasts in colorectal adenocarcinoma and serves as a potential stroma prognostic marker
- (2019) Ling Lu et al. Molecular Oncology
- Evaluation of integrin αvβ6 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis
- (2019) Richard H. Kimura et al. Nature Communications
- Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy
- (2019) Ping-Hsiu Wu et al. Cancers
- Recent progress in biomedical applications of RGD‐based ligand: From precise cancer theranostics to biomaterial engineering: A systematic review
- (2019) Mohsen Alipour et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics
- (2019) Fu Ou-Yang et al. LIFE SCIENCES
- From a Helix to a Small Cycle: Metadynamics-Inspired αvβ6 Integrin Selective Ligands
- (2018) Francesco Saverio Di Leva et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- An αv-RGD Integrin Inhibitor Toolbox: Drug Discovery Insight, Challenges and Opportunities
- (2018) Richard J. D. Hatley et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors
- (2018) Colin D. Weekes et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia
- (2018) Silje Johansen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- RGD peptide-based non-viral gene delivery vectors targeting integrin αvβ3 for cancer therapy
- (2018) Shuang Fu et al. JOURNAL OF DRUG TARGETING
- cRGD functionalised nanocarriers for targeted delivery of bioactives
- (2018) K. R. Gajbhiye et al. JOURNAL OF DRUG TARGETING
- N-Methylation of isoDGR Peptides: Discovery of a Selective α5β1-Integrin Ligand as a Potent Tumor Imaging Agent
- (2018) Tobias G. Kapp et al. JOURNAL OF MEDICINAL CHEMISTRY
- Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells
- (2018) Mara Vinci et al. NATURE MEDICINE
- Cellular tension encodes local Src-dependent differential β1 and β3 integrin mobility
- (2018) Richard De Mets et al. MOLECULAR BIOLOGY OF THE CELL
- NF-κB signaling and integrin-β1 inhibition attenuates osteosarcoma metastasis via increased cell apoptosis
- (2018) Rui Li et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- RGD-modified polymer and liposome nanovehicles: Recent research progress for drug delivery in cancer therapeutics
- (2018) Yu Cheng et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- RGD-mediated delivery of small-molecule drugs
- (2017) Sotirios Katsamakas et al. Future Medicinal Chemistry
- Fibronectin-bound α5β1 integrins sense load and signal to reinforce adhesion in less than a second
- (2017) Nico Strohmeyer et al. NATURE MATERIALS
- Integrin-targeted peptide- and peptidomimetic-drug conjugates for the treatment of tumors
- (2017) Daniela Arosio et al. Recent Patents on Anti-Cancer Drug Discovery
- αV-class integrins exert dual roles on α5β1 integrins to strengthen adhesion to fibronectin
- (2017) Mitasha Bharadwaj et al. Nature Communications
- Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update
- (2017) Laure Malric et al. Oncotarget
- Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers
- (2017) et al. Cancers
- Exploring the Role of RGD-Recognizing Integrins in Cancer
- (2017) Markus Nieberler et al. Cancers
- Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators
- (2017) Alessandra Tolomelli et al. Cancers
- Integrins as Therapeutic Targets: Successes and Cancers
- (2017) Sabine Raab-Westphal et al. Cancers
- A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins
- (2017) Tobias G. Kapp et al. Scientific Reports
- Antagonizing Integrin 3 Increases Immunosuppression in Cancer
- (2016) X. Su et al. CANCER RESEARCH
- Differential Effect on Bone Lesions of Targeting Integrins: Randomized Phase II Trial of Abituzumab in Patients with Metastatic Castration-Resistant Prostate Cancer
- (2016) M. Hussain et al. CLINICAL CANCER RESEARCH
- αvβ3 Integrin and tumour blood vessels—learning from the past to shape the future
- (2016) Fevzi Demircioglu et al. CURRENT OPINION IN CELL BIOLOGY
- Ligand-induced Epitope Masking
- (2016) A. Paul Mould et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- New β-Lactam Derivatives Modulate Cell Adhesion and Signaling Mediated by RGD-Binding and Leukocyte Integrins
- (2016) Monica Baiula et al. JOURNAL OF MEDICINAL CHEMISTRY
- In Vivo PET Imaging of the Cancer Integrin αvβ6 Using 68 Ga-Labeled Cyclic RGD Nonapeptides
- (2016) Johannes Notni et al. JOURNAL OF NUCLEAR MEDICINE
- Variation of Specific Activities of 68Ga-Aquibeprin and 68Ga-Avebetrin Enables Selective PET Imaging of Different Expression Levels of Integrins 5 1 and v 3
- (2016) J. Notni et al. JOURNAL OF NUCLEAR MEDICINE
- Relating conformation to function in integrin α5β1
- (2016) Yang Su et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rational design of a protein that binds integrin αvβ3 outside the ligand binding site
- (2016) Ravi Chakra Turaga et al. Nature Communications
- Selective binding and lateral clustering of α5β1 and αvβ3 integrins: Unraveling the spatial requirements for cell spreading and focal adhesion assembly
- (2016) Viktoria Schaufler et al. Cell Adhesion & Migration
- Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome
- (2016) Michael Weller et al. Oncotarget
- Insights into the Binding of Cyclic RGD Peptidomimetics to α5β1Integrin by using Live-Cell NMR And Computational Studies
- (2016) Ileana Guzzetti et al. ChemistryOpen
- Substrate engagement of integrins α5β1 and αvβ3 is necessary, but not sufficient, for high directional persistence in migration on fibronectin
- (2016) Dimitris Missirlis et al. Scientific Reports
- Stable Peptides Instead of Stapled Peptides: Highly Potent αvβ6-Selective Integrin Ligands
- (2015) Oleg V. Maltsev et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Development of the Fibronectin–Mimetic Peptide KSSPHSRN(SG)5RGDSP as a Novel Radioprobe for Molecular Imaging of the Cancer Biomarker α5β1 Integrin
- (2015) Zhao-Hui Jin et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Integrin α5β1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma
- (2015) G Renner et al. CELL DEATH AND DIFFERENTIATION
- ?v?3 Integrin-Targeted Peptide/Peptidomimetic-Drug Conjugates: In-Depth Analysis of the Linker Technology
- (2015) Alberto Dal Corso et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- In vivo biokinetic and metabolic characterization of the 68Ga-labelled α5β1-selective peptidomimetic FR366
- (2015) Calogero D’Alessandria et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 18F-FPRGD2 PET/CT Imaging of Integrin v 3 in Renal Carcinomas: Correlation with Histopathology
- (2015) N. Withofs et al. JOURNAL OF NUCLEAR MEDICINE
- Complementary, Selective PET Imaging of Integrin Subtypes 5 1 and v 3 Using 68Ga-Aquibeprin and 68Ga-Avebetrin
- (2015) J. Notni et al. JOURNAL OF NUCLEAR MEDICINE
- Optimization of RGD-Containing Cyclic Peptides against v 3 Integrin
- (2015) Y. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Definition of a consensus integrin adhesome and its dynamics during adhesion complex assembly and disassembly
- (2015) Edward R. Horton et al. NATURE CELL BIOLOGY
- Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study
- (2015) L. Burt Nabors et al. NEURO-ONCOLOGY
- Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
- (2015) Laetitia Seguin et al. TRENDS IN CELL BIOLOGY
- β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer
- (2015) Anne-Florence Blandin et al. Frontiers in Pharmacology
- Disruption of integrin–fibronectin complexes by allosteric but not ligand-mimetic inhibitors
- (2014) A. Paul Mould et al. BIOCHEMICAL JOURNAL
- Single cell tracking assay reveals an opposite effect of selective small non-peptidic α5β1 or αvβ3/β5 integrin antagonists in U87MG glioma cells
- (2014) Anne-Marie Ray et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Targeting integrins αvβ3 and α5β1 with new β-lactam derivatives
- (2014) Paola Galletti et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacophoric Modifications Lead to Superpotent αvβ3 Integrin Ligands with Suppressed α5β1 Activity
- (2014) Stefanie Neubauer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
- (2014) Roger Stupp et al. LANCET ONCOLOGY
- Structural basis for pure antagonism of integrin αVβ3 by a high-affinity form of fibronectin
- (2014) Johannes F Van Agthoven et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Selective Imaging of the Angiogenic Relevant Integrins α5β1 and αvβ3
- (2013) Stefanie Neubauer et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Activation of p53 pathway by Nutlin-3a inhibits the expression of the therapeutic target α5 integrin in colon cancer cells
- (2013) Hana Janouskova et al. CANCER LETTERS
- A Molecular Toolkit for the Functionalization of Titanium-Based Biomaterials That Selectively Control Integrin-Mediated Cell Adhesion
- (2013) Florian Rechenmacher et al. CHEMISTRY-A EUROPEAN JOURNAL
- Acute Depletion of Endothelial β3-Integrin Transiently Inhibits Tumor Growth and Angiogenesis in Mice
- (2013) Veronica Steri et al. CIRCULATION RESEARCH
- RCP-driven α5β1 recycling suppresses Rac and promotes RhoA activity via the RacGAP1–IQGAP1 complex
- (2013) Guillaume Jacquemet et al. JOURNAL OF CELL BIOLOGY
- RGD-based PET tracers for imaging receptor integrin αvβ3expression
- (2013) Hancheng Cai et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Biselectivity of isoDGR Peptides for Fibronectin Binding Integrin Subtypes α5β1 and αvβ6: Conformational Control through Flanking Amino Acids
- (2013) Alexander Bochen et al. JOURNAL OF MEDICINAL CHEMISTRY
- β1- and αv-class integrins cooperate to regulate myosin II during rigidity sensing of fibronectin-based microenvironments
- (2013) Herbert B. Schiller et al. NATURE CELL BIOLOGY
- Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs
- (2013) Neil C Henderson et al. NATURE MEDICINE
- Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors
- (2013) Florence Schaffner et al. Cancers
- Tumor Targeting via Integrin Ligands
- (2013) Udaya Kiran Marelli et al. Frontiers in Oncology
- An angiogenic role for the α5β1 integrin in promoting endothelial cell proliferation during cerebral hypoxia
- (2012) Longxuan Li et al. EXPERIMENTAL NEUROLOGY
- Crystal structure of α5β1 integrin ectodomain: Atomic details of the fibronectin receptor
- (2012) Masamichi Nagae et al. JOURNAL OF CELL BIOLOGY
- Cyclic Aza-peptide Integrin Ligand Synthesis and Biological Activity
- (2012) Jochen Spiegel et al. JOURNAL OF ORGANIC CHEMISTRY
- Integrins β1 and β3 exhibit distinct dynamic nanoscale organizations inside focal adhesions
- (2012) Olivier Rossier et al. NATURE CELL BIOLOGY
- Integrins and p53 pathways in glioblastoma resistance to temozolomide
- (2012) Sophie Martin et al. Frontiers in Oncology
- Increasing αvβ3 Selectivity of the Anti-Angiogenic Drug Cilengitide by N-Methylation
- (2011) Carlos Mas-Moruno et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
- (2011) Carlos Mas-Moruno et al. Anti-Cancer Agents in Medicinal Chemistry
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- TRAP, a Powerful and Versatile Framework for Gallium-68 Radiopharmaceuticals
- (2011) Johannes Notni et al. CHEMISTRY-A EUROPEAN JOURNAL
- Volociximab in cancer
- (2011) Salah Almokadem et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer
- (2011) Katherine M. Bell-McGuinn et al. GYNECOLOGIC ONCOLOGY
- Conformational Control of Integrin-Subtype Selectivity in isoDGR Peptide Motifs: A Biological Switch
- (2010) Andreas O. Frank et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- α5β1 integrin antagonists reduce chemotherapy-induced premature senescence and facilitate apoptosis in human glioblastoma cells
- (2010) Eva Martinkova et al. INTERNATIONAL JOURNAL OF CANCER
- The Use of One-Bead One-Compound Combinatorial Library Technology to Discover High-Affinity v 3 Integrin and Cancer Targeting Arginine-Glycine-Aspartic Acid Ligands with a Built-in Handle
- (2010) W. Xiao et al. MOLECULAR CANCER THERAPEUTICS
- Preclinical Evaluation of the Novel Small-Molecule Integrin α5β1 Inhibitor JSM6427 in Monkey and Rabbit Models of Choroidal Neovascularization
- (2009) Grit Zahn ARCHIVES OF OPHTHALMOLOGY
- Cyclic RGD-Peptidomimetics Containing Bifunctional Diketopiperazine Scaffolds as New Potent Integrin Ligands
- (2009) Ana Sofia M. da Ressurreição et al. CHEMISTRY-A EUROPEAN JOURNAL
- Dissection of platelet and myeloid cell defects by conditional targeting of the β3-integrin subunit
- (2009) Elizabeth A. Morgan et al. FASEB JOURNAL
- Anti-integrin monoclonal antibodies
- (2009) A. Byron et al. JOURNAL OF CELL SCIENCE
- Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors
- (2009) Andrew R Reynolds et al. NATURE MEDICINE
- Imaging of integrin αvβ3 expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography
- (2009) Oliver Schnell et al. NEURO-ONCOLOGY
- Caveolin-1 regulates glioblastoma aggressiveness through the control of α5β1 integrin expression and modulates glioblastoma responsiveness to SJ749, an α5β1 integrin antagonist
- (2008) Sophie Martin et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Rational Design of Highly Active and Selective Ligands for the α5β1 Integrin Receptor
- (2008) Dominik Heckmann et al. CHEMBIOCHEM
- A Potent Integrin Antagonist from a Small Library of Cyclic RGD Pentapeptide Mimics Including Benzyl-Substituted Azabicycloalkane Amino Acids
- (2008) Daniela Arosio et al. ChemMedChem
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started